ENTERO vs PRAVEG: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows a higher ROE, faster revenue growth and lower leverage, while PRAVEG shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 10; PRAVEG leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | PRAVEG |
|---|---|---|
| Sector | Consumer Services | — |
| Industry | Pharmacy Retail | — |
Price
| Metric | ENTERO | PRAVEG |
|---|---|---|
| Live Price | ₹1,503.9 | ₹226.37 |
| Day Change | -5.12% | -2.24% |
| Volume | 1.65 L | 16,324 |
| 52-Week High | ₹1,920 | ₹325 |
| 52-Week Low | ₹944 | ₹210.4 |
| Distance from 52W High | -21.67% | -30.35% |
Valuation
| Metric | ENTERO | PRAVEG |
|---|---|---|
| Market Cap | ₹6,558 Cr | ₹599 Cr |
| P/E Ratio | 52.28x | 0x |
| P/B Ratio | 3.88x | 1.33x |
| EPS | ₹8.77 | ₹-5.17 |
| Book Value | ₹402.67 | ₹178.38 |
| Dividend Yield | 0% | 0.22% |
Growth
| Metric | ENTERO | PRAVEG |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | 0% |
| EPS Growth (TTM YoY) | 9.1% | 0% |
| Qtr Sales Growth | 0% | -37.49% |
| Qtr Profit Growth | 0% | -168.44% |
Profitability & Leverage
| Metric | ENTERO | PRAVEG |
|---|---|---|
| ROE | 1.6% | -2.76% |
| ROCE | 2.01% | -0.09% |
| Net Margin | 1.75% | -4.14% |
| Operating Margin | 9.99% | -0.23% |
| Debt to Equity | 0.06x | 0.09x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | PRAVEG |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | 46.18%▲ 0.12 pp |
| FII Holding | 4.37%▲ 0.34 pp | 1.83%▼ 0.9 pp |
| DII Holding | 15.48%▼ 1.14 pp | 3.79%▼ 0.86 pp |
| Public Holding | 27.75%▲ 0.82 pp | 48.2%▲ 1.64 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and PRAVEG.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.